Hippocampal volumes of subjects with a history of major depressive episodes but currently in remission and with no known medical comorbidity were compared to matched normal controls by using volumetric magnetic resonance images. Subjects with a history of major depression had significantly smaller left and right hippocampal volumes with no differences in total cerebral volumes. The degree of hippocampal volume reduction correlated with total duration of major depression. In addition, large (diameter 2 4.5 mm)-hippocampal low signal foci (LSF) were found within the hippocampus, and their number also correlated with the total number of days depressed. These results suggest that depression is associated with hippocampal atrophy, perhaps due to a progressive process mediated by glucocorticoid neurotoxicity. (14, 15) , decreased the possibility of hypertension and occult cardiovascular disease, and increased the ability to obtain subjects, although at the cost of generalizability. Each depressed subject was matched using a case-control design for age and educational level, and the groups were matched overall for height, since this variable is a predictor of overall brain size (16). Potential subjects were screened by questionnaire, medical history, review of medical records, and physical exam to exclude those with medical problems potentially affecting the central nervous system, such as a current or past neurological disorder, head trauma, hypertension, myocardial infarction or ischemia, diabetes, Cushings disease, steroid use, or drug/ alcohol abuse. These exclusionary criteria were consistent with routine Alzheimer's Disease Research Center screening criteria (17). In addition, subjects who had received more than three courses of electroconvulsive therapy (ECT) were excluded. Three subjects included in the study had received ECT previously during the course of their treatment, and the time elapsed since last ECT treatment was 34, 30, and 14 years. All subjects gave informed consent.
Hippocampal volumes of subjects with a history of major depressive episodes but currently in remission and with no known medical comorbidity were compared to matched normal controls by using volumetric magnetic resonance images. Subjects with a history of major depression had significantly smaller left and right hippocampal volumes with no differences in total cerebral volumes. The degree of hippocampal volume reduction correlated with total duration of major depression. In addition, large (diameter 2 4.5 mm)-hippocampal low signal foci (LSF) were found within the hippocampus, and their number also correlated with the total number of days depressed. These results suggest that depression is associated with hippocampal atrophy, perhaps due to a progressive process mediated by glucocorticoid neurotoxicity.
Dysregulation of the hypothalamic-pituitary-adrenal axis resulting in hypercortisolemia has been studied for many years as a biological characteristic of acute major depression (1) . Young et al. (2) have shown that depression is accompanied by dysregulation in the fast-feedback control of cortisol secretion, possibly at the level of the hippocampus. Work in experimental systems suggests that this disinhibition can be induced by chronic corticosteroid exposure or by stress alone (3, 4) .
The precise mechanisms by which stress or depression disturb hippocampal regulation of cortisol function are unknown, but recent studies have raised the possibility that neurotoxic tissue damage is involved. The work of Sapolsky et al. (3, 5, 6) has demonstrated that rats injected repeatedly with glucocorticoids develop hippocampal neuronal loss, perhaps due to enhanced neuronal vulnerability to glutamate neurotoxicity (7) . Rats exposed to stress (8) or exposed relatively briefly to glucocorticoids (daily injection for 3 weeks) (9) have shortening and atrophy of hippocampal dendritic processes.
These experimental studies raise the possibility that humans experiencing recurrent depressive episodes and elevated levels of glucocorticoids might also sustain neurotoxic damage to hippocampal neurons. While adequate pathological studies have not been conducted to test this hypothesis in affective disorders (10) , a radiologic hallmark of such neurotoxic damage might be hippocampal volume loss. Supporting this idea, a recent volumetric magnetic resonance image (MRI) study has demonstrated right-sided hippocampal volume decrease in combat-related posttraumatic stress disorder (11) . To date, however, no evidence of hippocampal volume loss has been found in association with major depression (12) , although MRI abnormalities in hippocampal spin-lattice relaxation time (T1) characteristics have been reported (13) .
The present study evaluated hippocampal volume in older women with recurrent major depression by using highresolution MRI and stereological measurement. Based on the glucocorticoid hypothesis described above, we hypothesized that hippocampal volume loss related to depression would be age-and duration-dependent. To (14, 15) , decreased the possibility of hypertension and occult cardiovascular disease, and increased the ability to obtain subjects, although at the cost of generalizability. Each depressed subject was matched using a case-control design for age and educational level, and the groups were matched overall for height, since this variable is a predictor of overall brain size (16 (17) . In addition, subjects who had received more than three courses of electroconvulsive therapy (ECT) were excluded. Three subjects included in the study had received ECT previously during the course of their treatment, and the time elapsed since last ECT treatment was 34, 30, and 14 years. All subjects gave informed consent.
All subjects were assessed clinically by a psychiatrist (Y.I.S.) experienced in the use of the diagnostic interview for genetic studies (DIGS), a structured interview with high reliability (18) . The state-dependent changes (e.g., hypercortisolemia) in MRI volumetric measurements, and none of the subjects had been acutely depressed within the past 6 months. Eight of the 10 depressed subjects were receiving antidepressants: selective serotonin reuptake inhibitors in three cases, tricyclic antidepressants in three cases, and maprotiline and trazodone in one case each. Antidepressant status and doseage in milligrams were determined. Two patients had previously been treated with neuroleptics, one with chlorpromazine and one with haloperidol. In both cases the duration of treatment was brief, and neither patient was psychotic at the time of treatment. Patients and controls were also assessed using the Hamilton rating scale for depression (HRSD) (19) (20) . First, images were interpolated from 1.25-mm sections to 0.5-mm sections. Next, images were reoriented to the anterior commissure-posterior commissure plane (21) for standard alignment. To minimize inter-scan variations, MRIs underwent gray scale normalization as described (22) . Gray scale histograms of cylindrical regions-of-interest subvolumes inclusive of the hippocampus were generated to aid in tissue classification. These subvolumes were analyzed using PEAKFIT software (Jandel Scientific, San Rafael, CA) by the Marquardt-Levenberg algorithm for nonlinear curve fitting (23, 24) as described (22) . Trilinear scaling of magnetic resonance data to 8-bit gray scale resolution was performed using these calculated thresholds to generate data sets with high contrast between gray and white matter. To save image loading time and memory and to increase the regions-of-interest volume occupied by the hippocampus, left and right medial temporal lobe cubical subvolumes were interactively defined by an expert observer (Fig. la) .
Stereologic Method and Reliability. Two raters (Y.I.S. and P.W.W.) measured unilateral hippocampal gray matter volumes after extensive training and assessment standardization with a neuroradiologist expert in hippocampal anatomy (M.G.). Volume determination was based on stereologic estimation methods, which have been used with precision in microscopy and magnetic resonance volumetry (25, 26) . From three-dimensional MRI cubical subvolumes composed of 0.5 x 0.5 x 0.5-mm voxels, coronal slices were sampled every 1.5 mm from a randomly chosen start slice. A 7 X 7-mm2 rigid grid of points, with random starting position and angle of deviation from horizontal, was then superimposed on the images. Grid points falling within the hippocampal gray matter (see definition of hippocampus below) were counted. The ANALYZE program allows viewing of grid points simultaneously in three orthogonal perspectives: sagittal, axial, and coronal ( This provided greater clarity of anatomic localization. Based on the number of selected grid points, a volume estimate was extrapolated by ANALYZE. Raters were blind to subject identity and clinical characteristics. Raters measured left and right hippocampi separately. Mean volumes were determined from the average of four measurements of each volume, two measurements each by two independent raters. The SpearmanBrown prediction formula was used to determine intra-rater and inter-rater reliability (27 (28) . However, orthogonal slices could be inspected as needed (see above). A voxel size of 0.5 mm3 was chosen to achieve maximal resolution while maintaining a workable data set size. Inter-slice distance and grid size were chosen to yield a CE in the 0.02-0.04 range. Selecting the optimal numbers of slices and grid sizes are essential for assessing structurally complex objects whose profiles change significantly from slice to slice. Based on prior studies (22) , an inter-slice distance of 1.5 mm, or every third slice, and a 7 x 7-mm2 grid size resulted in volumes with CEs in the desired range.
Anatomic Definition ofthe Hippocampus. Specific rules (29, 30) were used to define anatomical boundaries as follows. (i) Every third coronal slice was assessed, beginning randomly from one of the first three slices at the posterior end of the volume. Orthogonal views were consulted in cases of anatomic uncertainty, though the coronal view retained priority. (ii) Posteriorly, the tail of the hippocampus continues as the indusium griseum, a thin strip of gray matter overlying the surface of the corpus callosum. For purposes of measurement, the posterior-most slice for volumetry was defined as the slice where the hippocampus first appeared adjacent to the trigone of the lateral ventricle. (iii) Volumetrically included tissues were an elongated gray matter complex bordered superiorly by the fornix-fimbria white matter junction, inferiorly by parahippocampal gyrus white matter, medially by the subarachnoid spaces of various cisterns (e.g., ambient cistern), and laterally by the cerebrospinal fluid-filled lateral ventricle. The gray matter complex included the cornu ammonis, dentate gyrus, and subiculum (i.e., the head and body of the hippocampus were included). The vertical digitation of the head of the hippocampus, which curves up and medial to the amygdala in coronal sections was included. (iv) Volumetrically excluded tissues were the fornix-fimbria white matter complex; the alveus (the intraventricular white matter covering of the hippocampus); the white matter of the parahippocampal gyrus; various fluid-filled spaces including ventricles, subarachnoid spaces, and sporadic fluid-density spaces in the hippocampus complex; and the amygdala proper and the white matter border with it (a thin white matter line, discernible in 0.5-mm3 MRIs, which separated the hippocampus from the amygdala). When necessary, we used an arbitrary line connecting the sulcus semiannularis and the inferior horn of the lateral ventricle to define this separation (31) .
The subiculum is a long stretch of tissue, extending medially from the cornu ammonis-. The superior component of the cornu ammonis does not extend medially far enough to aid in demarcating the border of the hippocampus, and the inferior component of the cornu ammonis is in direct continuity with the subiculum. Therefore, no clear gross anatomic separation exists among the hippocampus, subiculum, presubiculum, or parasubiculum. For practical purposes, we adopted a precedence to include the subiculum in the measured volume called "hippocampus" (30 Neuromorphometric Measures. Table 1 and Fig. 2 show that left and right hippocampal gray matter volumes were smaller and the number of large LSF in left and right hippocampus were larger in depressed subjects than in normal controls.
Mean total cerebral volumes did not differ. Correlations between number of large LSF and hippocampal gray matter volumes were determined. For left hippocampal gray matter volumes, the correlation with left large LSF was p = -0.56 (P = 0.01). The correlation between right hippocampal gray matter volumes and large LSF was p = -0.53 (P = 0.02).
Correlations Between Hippocampal Gray MatterVolumes and Total Time Depressed. There was a significant correlation between total days depressed and left hippocampal gray matter volume (r = -0.65; P = 0.04) (Fig. 3) . There was also a trend toward a relationship between right hippocampal gray matter volume and total days depressed (r = -0.59; P = 0.10). In addition, the correlation between hippocampal LSF and total days depressed was determined (Fig. 4) . The number of large LSF in left (p = 0.76, P = 0.02) and right (p = 0.66, P = 0.05) hippocampus were significantly correlated with total number of days depressed.
DISCUSSION
The major finding of the present study is that patients with a history of recurrent major depression, but with no current depression or history of medical comorbidity, had smaller hippocampal gray matter volumes than a group of pair-wise matched normal controls. This reduction was not a result of overall brain atrophy; total cerebral volumes did not differ between the groups. In examining the left and right hippocampus individually, both differed significantly between depressed patients and controls.
Present data contrast with those obtained by a previous study that found no hippocampal volume differences between depressed patients and controls (12) . This discrepancy may be explained by methodological differences. We achieved higher spatial resolution examining 0.5-mm slices rather than the 5-mm slices used by Axelson et al. (12) , and we isolated hippocampal gray matter volume rather than assessing combined gray and white matter volume of the combined hippocampus-amygdala complex. These technical differences may have enhanced our ability to detect small differences specific to hippocampal gray matter volume.
An important aspect of this study design is that the depressed individuals were not currently suffering from depression. Therefore, the results reported are not likely due to the acute effects of corticosteroids, but rather appear to be a con- 
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sequence of the cumulative depression history. This study is limited by its retrospective nature, and we were unable to correlate hypercortisolism with hippocampal atrophy. However, it is interesting to note that both combat and depression are stressors, and both appear to be associated with hippocampal atrophy (11) , even in the absence of hypercortisolism (38) after the acute stress has resolved. In fact, posttraumatic stress disorder is associated with decreased urinary cortisol excretion which can continue for decades after the initial trauma (39) . Evidence for the neurotoxic effects of corticosteroids in humans is also provided by the finding that patients with Cushings syndrome have selective hippocampal atrophy, which is correlated with plasma cortisol levels (40) and memory dysfunction. Our finding that MRI cerebral volumes in depressed patients and controls were not significantly different is consistent with some previous reports (41) , but different from that of Rabins et al. (42) , who found widespread cortical and subcortical atrophy in geriatric patients with major depression, and Rothschild et al. (43) , who found larger ventricle-to-brain ratios indicative of cortical atrophy in depressed patients with abnormal dexamethasone suppression tests. To our knowledge, however, the present study is the first to study only subjects without medical or neurological comorbidities capable of affecting brain volume. It is critical to know whether patients with changes in brain structure volumes had concurrent physical illnesses, especially with agerelated increases in incidence of medical conditions potentially affecting the brain (44, 45) . Before concluding that specific regional volume decrements are associated with depression, this possibility must be excluded. While previous studies have included a physical exam to exclude significant neurological illness, common medical conditions, such as hypertension, diabetes, and history of myocardial infarct, have not been specifically excluded. In the present study, we selected only subjects with no current medical or neurological condition and made special effort to exclude subjects with cerebrovascular disease risk factors that could increase the incidence of subclinical infarcts. An increased incidence of microinfarction has been linked to both chronic hypertension (46) and diabetes (47, 48) . We also excluded patients with any history of substance abuse or dependence, since alcohol dependence can cause cerebral atrophy (49) .
Further study will be needed to determine the exact nature of the observed association between recurrent depression and the Proc. Natl. Acad. Sci. USA 93 (1996) hippocampal volume reduction. We cannot exclude the possibility that the loss of hippocampal volume preceded the development of depression, or that this volume reduction is a signature of some brain abnormality that predisposes to depression. However, we favor the alternative possibility that the recurrent episodes of depression actually caused hippocampal neuronal loss, perhaps through the mechanism of glucocorticoid-induced neurotoxicity (7) . Favoring this possibility, the extent of left hippocampal volume loss in depressed subjects correlated with total lifetime cumulative duration of depression. Furthermore, large (diameter -4.5 mm) hippocampal LSF were found, and their number also correlated with the total number of days depressed. To our knowledge, this is the first report of such lesions in the hippocampus and we attribute them to atrophy.
One confound in this and other studies to date is ECT therapy. While direct evidence to date demonstrating ECTinduced structural brain changes has been lacking (50), animal studies suggest that sustained seizures can produce neuronal loss and gliosis in the hippocampus (51) , and more recent study (52) has suggested that even brief kindled seizures may also induce some selective hippocampal neuronal loss. It was impractical to exclude patients who had received any ECT, since to do so would exclude the patients with the most severe histories of depression. However, we did exclude from the study any patient with more than three courses of ECT treatment or anyone with a history of ECT within the past year. Even if the three subjects who received ECT were excluded in a post hoc analysis, however, there were still significant differences in left (P = 0.007) and right (P = 0.05) hippocampal gray matter volumes between depressed subjects and normal controls. In addition, there was still a significant correlation between total days depressed and left hippocampal gray matter volume (P = 0.03). Another confound was medication treatment. While there is no known evidence for reductions in brain structure volumes associated with neuroleptics or antidepressants, this possibility cannot be excluded. The relationship between hippocampal gray matter volume with duration of depression appears to be fairly specific because no relationship was found between hippocampal volumes and other clinical variables in post hoc analyses. The variables examined were average number of depressive symptoms, duration of depression weighted by severity, and time since most recent episode of depression. There was no correlation between average severity of depression and hippocampal volumes (P = 0.46, 0.20, 0.29 for the correlations with left, right, and total hippocampal volumes, respectively). When the duration of depression was weighted for severity (this was done by multiplying the duration of each episode of depression by its severity and summing over all episodes), there was also no correlation with hippocampal volumes (P = 0.21, 0.38, 0.23 for the correlations with left, right, and total hippocampal volumes, respectively). This may suggest that above the threshold of symptoms sufficient to meet criteria for major depression, additional symptoms do not further increase the degree of hippocampal atrophy. There was no correlation between time since most recent episode of depression and hippocampal volumes (P = 0.10, 0.52, 0.26 for the correlations with left, right, and total hippocampal volumes, respectively). The lack of correlation was not surprising since the potential acute effects of hypercortisolemia could be expected to be resolved by 6 months, the smallest elapsed time since depression in our study, although resolution of brain effects of hypercortisolemia have not been systematically studied.
In conclusion, the present study provides evidence supporting the possibility that depression per se is associated with structural changes in the hippocampus, perhaps reflecting neuronal loss. Such hippocampal damage might be responsible for an increase in corticotropin-releasing factor secretory drive that contributes to the hypothalamic-pituitary-adrenal axis abnormalities seen in depression (53) . In combination with the loss of negative feedback inhibition described above (2) , this could lead to enhanced vulnerability to subsequent depression through a feed-forward cycle of depression-hippocampal damage-depression, occurring with each episode of major depression. Neuroprotective approaches directed at preventing depression and reducing this hippocampal damage might ameliorate the severe morbidity associated with this disorder in later life.
